STOCK TITAN

InMode (Nasdaq: INMD) authorizes new buyback for about 10% of shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

InMode Ltd. announced that its Board of Directors has approved a new share repurchase program for up to approximately 10% of the company’s total shares outstanding, or about 6.38 million ordinary shares. The company plans to fund the buybacks with available cash and may execute them in the open market or through other permitted methods, subject to market conditions and legal requirements.

In 2025, InMode repurchased approximately $127.4 million of its ordinary shares, and management describes the current valuation as an attractive use of capital, despite a challenging macroeconomic environment and ongoing regional conflict. The program can be modified, suspended, or discontinued at the company’s discretion.

Positive

  • Substantial new buyback authorization: Board approved a share repurchase program for up to approximately 10% of total shares outstanding, or about 6.38 million ordinary shares, indicating confidence in the company’s valuation and cash-generation profile.
  • Proven track record of capital return: InMode repurchased approximately $127.4 million of ordinary shares in 2025 and plans to fund the new program with available cash, underscoring strong cash flow despite a challenging macroeconomic environment.

Negative

  • None.

Insights

InMode’s new buyback of up to 10% signals confidence and continued cash generation.

InMode has authorized a share repurchase program covering up to approximately 10% of total shares outstanding, or about 6.38 million ordinary shares. This follows roughly $127.4 million of buybacks in 2025, indicating an ongoing commitment to returning capital.

Management highlights strong cash flow despite a challenging macroeconomic backdrop and regional conflict, and plans to fund repurchases with available cash. Actual buyback volume and timing will depend on market conditions and the company’s evolving capital allocation priorities.

The board can modify, suspend, or discontinue the program at any time, so subsequent disclosures in future company filings will clarify how much of the authorized amount is ultimately executed and over what period.



SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934

For the month of March 2026


INMODE LTD.


(Exact name of registrant as specified in its charter)

Tavor Building, Sha’ar Yokneam
P.O. Box 533
Yokneam 2069206 Israel
 
(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒          Form 40-F ☐ 

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes ☐          No ☒ 



On March 13, 2026, InMode Ltd. (the “Company”) announced that the Company’s Board of Directors authorized the repurchase of up to 10% of the Company’s outstanding ordinary shares, par value NIS 0.01 per ordinary share, in accordance with the terms of Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended, from time to time in the open market or otherwise, in such quantities, at such prices, in such manner and on such terms and conditions as determined to be in the best interests of the Company, as disclosed in the press release.

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Exhibit No.
 
Description of Exhibit
99.1

Press Release dated March 13, 2026
 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
InMode Ltd.
 
 
 
By: /s/ Moshe Mizrahy
 
Moshe Mizrahy
 
March 13, 2026
Chief Executive Officer




Exhibit 99.1


InMode Announces New Share Repurchase Program

YOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the Company’s total shares outstanding, representing approximately 6.38 million ordinary shares.

In 2025, the Company repurchased approximately $127.4 million of its outstanding ordinary shares through share repurchase programs. Despite a challenging macroeconomic environment, the Company continues to generate strong cash flow and believes that repurchasing shares at its current valuation represents an attractive use of capital.

While management remains focused on navigating the ongoing regional conflict and maintaining a disciplined approach to capital allocation, the Company will continue to evaluate additional share repurchase programs and other capital allocation opportunities going forward.

The Company expects to fund repurchases under the program with available cash. Repurchases may be made from time to time in the open market or through other permitted means, subject to market conditions and applicable legal requirements. The program may be modified, suspended, or discontinued at any time at the Company’s discretion.

About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com/.

Forward-Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

Company Contact:
Yair Malca
Chief Financial Officer
Phone: (949) 305-0108
Email: Yair.Malca@inmodemd.com
Investor Relations Contact
Miri Segal
MS-IR LLC
Email: ir@inmodemd.com


FAQ

What did InMode (INMD) announce in its March 2026 Form 6-K?

InMode announced Board approval of a new share repurchase program for up to approximately 10% of its total shares outstanding, or about 6.38 million ordinary shares, to be funded with available cash and executed subject to market conditions and legal requirements.

How large is InMode’s new share repurchase program in terms of shares?

The new repurchase program covers up to approximately 10% of InMode’s total shares outstanding, representing about 6.38 million ordinary shares. Purchases may occur over time in the open market or through other permitted methods, depending on market conditions and regulatory requirements.

How much stock did InMode (INMD) repurchase in 2025?

InMode repurchased approximately $127.4 million of its outstanding ordinary shares in 2025 through share repurchase programs. This history of buybacks provides context for the newly authorized program of up to roughly 10% of total shares outstanding announced in March 2026.

How will InMode fund the new share repurchase program?

InMode expects to fund repurchases under the new program with available cash. Management notes the company continues to generate strong cash flow, and considers buying back shares at the current valuation an attractive use of capital despite a challenging macroeconomic environment.

Can InMode change or stop its 2026 share repurchase program?

Yes. The company states the repurchase program may be modified, suspended, or discontinued at any time at its discretion. Actual repurchase activity will depend on factors such as market conditions, legal requirements, and InMode’s ongoing capital allocation priorities and opportunities.

Why does InMode believe share repurchases are attractive now?

InMode believes repurchasing shares at its current valuation is an attractive use of capital. The company highlights continued strong cash flow generation despite a challenging macroeconomic environment and ongoing regional conflict, while management remains focused on disciplined capital allocation decisions.

Filing Exhibits & Attachments

1 document
Inmode Ltd.

NASDAQ:INMD

View INMD Stock Overview

INMD Rankings

INMD Latest News

INMD Latest SEC Filings

INMD Stock Data

808.46M
56.53M
Medical Devices
Healthcare
Link
Israel
Yokne'am